| Bioactivity | S07-2008 is a selective aldo-keto reductase family 1 member C3 (AKR1C3) inhibitor with an IC50 of 0.16 μM. S07-2008 shows anticancer activities[1]. |
| Target | IC50: 0.16 μM (AKR1C3) |
| Name | S07-2008 |
| CAS | 1090816-80-0 |
| Formula | C21H23N3O5S |
| Molar Mass | 429.49 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Siyu He, et al. Discovery of Novel Aldo-Keto Reductase 1C3 Inhibitors as Chemotherapeutic Potentiators for Cancer Drug Resistance. ACS Medicinal Chemistry Letters, 2022. |
S07-2008
CAS: 1090816-80-0 F: C21H23N3O5S W: 429.49
S07-2008 is a selective aldo-keto reductase family 1 member C3 (AKR1C3) inhibitor with an IC50 of 0.16 μM. S07-2008 sho
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.